Is the end of the recombinant DNA Advisory Committee (RAC) a good thing?

(Mary Ann Liebert, Inc./Genetic Engineering News) Recently, the U.S. National Institutes of Health (NIH) and Food and Drug Administration (FDA) called for the eliminating involvement of the Recombinant DNA Advisory Committee (RAC) in human gene therapy experiments, marking the end of an era of federal government oversight.
Source: EurekAlert! - Biology - Category: Biology Source Type: news